Haplo-Cord HSCT for AML/MDS

Clinical trial NCT07588360 · RECRUITING

Trial details

NCT number: NCT07588360
Sponsor: Fujian Medical University Union Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

MDS (Myelodysplastic Syndrome)AML (Acute Myeloid Leukemia)

Start date: 2025-10-20
Primary completion: 2028-10-20
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.